NCT06833424Not yet recruiting
Dural Venous Sinus Stent in Idiopathic Intracranial Hypertension
Predictors of Dural Venous Sinus Stenting in Idiopathic Intracranial Hypertension Patients and Outcomes
Source: ClinicalTrials.gov · Last updated 18 Feb 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This study aims to identify clinical determinants and factors that predict outcome including primary outcome and secondary outcome depending on factors in individual patients with Idiopathic intracranial hypertension treated by Dural venous sinus stenting.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- First submitted
- 13 Feb 2025
- Start date
- 1 Mar 2025
- Primary completion date
- 1 Mar 2026
- Lead sponsor
- Assiut University
- Diseases
- High blood pressure
- NCT number
- NCT06833424
What you commit to
- Study type: Interventional
- Planned participants: 40
- From 1 Mar 2025 to the primary completion date, 1 Mar 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- severe allergic reaction to iodine contrast or chronic Kidney disease.
- patients with secondary causes of intracranial hypertension: Dural arteriovenous fistula or other arteriovenous lesion affecting cortical venous flow.
Age
- Age less than or equal to 18 years.
Other
- contraindication to general anesthesia or antiplatelet anticoagulants, Hemorrhagic Diathesis
- pregnancy.
Who the study is looking for
- 40 Patients of idiopathic intracranial hypertension subjected to Dural venous sinus stenting met the modified Dandy criteria for (IIH).
- Signs and symptoms of increased intracranial pressure: Headaches, nausea, vomiting, visual changes, and papilledema.
- No localizing or focal neurologic signs: Except for possible unilateral or bilateral VI nerve paresis.
- Elevated cerebrospinal fluid (CSF) pressure: Without cytologic or chemical abnormalities.
- No etiology for increased intracranial pressure: On neuroimaging findings.
- Age: 18-60 years
- Gender: Male or Female Inclusion Criteria.
Age in the registry: 18 years to 60 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Faculty of medicine Coordinator of this site? Confirm its status | Asyut | Egypt | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.